Center for Integrated Management of Antimicrobial Resistance

The Center for Integrated Management of Antimicrobial Resistance is a center for research and education focusing on pathogens that exhibit antimicrobial resistance located at Tufts University and Tufts Medical Center.

History

The Center for Integrated Management of Antimicrobial Resistance (CIMAR) was founded by Tufts University and Tufts Medical Center in 2018. CIMAR was established in order to provide a response to ‘superbug’ epidemics.[1] The founding co-directors of the center were Helen Boucher and Ralph Isberg.[2][3] Researchers associated with CIMAR include Maya Nadimpalli[4] and Stuart Levy.[5]

The founding priorities of the center were to “Investigate combination drug therapies that both treat infection and reduce the emergence of resistance in humans and animals,” “Utilize tools from epidemiology, engineering and the social sciences to develop new methods for controlling and preventing the spread of AMR,” and “Develop educational programs for high school, college, graduate and professional students in order to increase AMR awareness,” with the goal of developing future researchers and raising community awareness.[1]

References
  1. "Tufts University, Tufts Medical Center Launch Center for Study of Antimicrobial Resistance". Infection Control Today.
  2. "Tufts Medical Center takes on life-threatening superbug infections". March 8, 2019.
  3. Gormley, Brian (18 July 2019). "Antibiotics Developers Seek a Cure for Industry Ills". Wall Street Journal.
  4. Gewin, Virginia (21 June 2019). "A battle against antibiotic resistance". Nature. doi:10.1038/d41586-019-01962-5.
  5. "Remembering Stuart Levy". Tufts Now. September 12, 2019.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.